Patents by Inventor Kevin Paul Girard

Kevin Paul Girard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210387989
    Abstract: The present invention discloses a novel p-toluenesulfonic acid salt and a crystalline polymorphic Form 1 of said salt of 1-((2S,5R)-5-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one, pharmaceutical composition containing the same, as well as preparations and uses thereof. The present invention also discloses a novel phosphoric acid salt of 1-((2S,5R)-5-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one, pharmaceutical composition containing the same, as well as preparations and uses thereof.
    Type: Application
    Filed: October 21, 2019
    Publication date: December 16, 2021
    Applicant: Pfizer Inc.
    Inventors: Brian Matthew SAMAS, Yong TAO, Douglas James Critcher, David Sydney Bernard Daniels, Kevin Paul Girard, Gregory Scott Goeken, Peter Robert Rose
  • Publication number: 20170273953
    Abstract: The present invention relates to solid forms of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole and to methods for their preparation. The invention is also directed to pharmaceutical compositions containing at least one solid form and to the therapeutic or prophylactic use of such solid forms and compositions.
    Type: Application
    Filed: August 31, 2015
    Publication date: September 28, 2017
    Applicant: Pfizer Inc.
    Inventors: Kevin Paul GIRARD, Andrew J. JENSEN, Kris Nicole JONES
  • Patent number: 9770441
    Abstract: The present invention relates to solid forms of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole and to methods for their preparation. The invention is also directed to pharmaceutical compositions containing at least one solid form and to the therapeutic or prophylactic use of such solid forms and compositions.
    Type: Grant
    Filed: August 31, 2015
    Date of Patent: September 26, 2017
    Assignee: Pfizer Inc.
    Inventors: Kevin Paul Girard, Andrew J. Jensen, Kris Nicole Jones